References

nogr

Экспериментальная и клиническая гастроэнтерология

Experimental and Clinical Gastroenterology

1682-8658

«Global Media Technologies»

10.31146/1682-8658-ecg-195-11-5-14

nogr-1776

Research Article

ПЕРЕДОВАЯ СТАТЬЯ

LEADING ARTICLE

Обзор клинических рекомендаций по диагностике и лечению экзокринной панкреатической недостаточности

A brief review of clinical guidelines for the diagnosis and treatment of exocrine pancreatic insufficiency

https://orcid.org/0000-0001-7760-2091

Кучерявый

Ю. А.

Kucheryavyy

Yu. A.

Кучерявый Юрий Александрович, к. м. н., доцент, заведующий отделением гастроэнтерологии

143421. Московская область, г. о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2, корп.2

Yuri A. Kucheryavyy, Ph.D., Associate Professor, Head of the Department of Gastroenterology

143421. Moscow region, g. Krasnogorsk, Glukhovo village, st. Rublevskoe suburb, 2, building 2

proped@mail.ru

https://orcid.org/0000-0003-2815-3992

Бордин

Д. С.

Bordin

D. S.

Бордин Дмитрий Станиславович, д. м. н., зав. отделом патологии поджелудочной железы, желчных путей и верхних отделов пищеварительного тракта; профессор кафедры пропедевтики внутренних болезней и гастроэнтерологии; профессор кафедры поликлинической терапии и семейной медицины

111123, Москва, ш. Энтузиастов, 86Москва, 127473, ул. Делегатская, д. 20, стр.1Тверь, 170100, улица Советская, дом 4

Dmitry S. Bordin, MD, PhD, Head of the Department of Pancreatic, Biliary and upper digestive tract disorders; professor of the department of outpatient therapy and family medicine; professor of the department of propaedeutic of internal diseases and gastroenterology

111123, Entuziastov Shosse,86, Moscow20, building 1, st. Delegatskaya, Moscow, 1274734, Sovetskaya street, Tver, 170100

АО Ильинская больницаРоссияIlyinsky hospitalRussian Federation

Московский клинический научно-практический центр им. А. С. Логинова; Московский государственный медико-стоматологический университет им. А. И. Евдокимова; Тверской государственный медицинский университетРоссияA.S. Loginov Moscow clinical scientific center; A.I. Yevdokimov Moscow State University of Medicine and Dentistry; Tver State Medical UniversityRussian Federation

2021

02012022

011514

2022

Кучерявый Ю.А., Бордин Д.С.

Kucheryavyy Y.A., Bordin D.S.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.nogr.org/jour/article/view/1776

В последние годы были опубликованы несколько консенсусов и рекомендаций по диагностике и лечению хронического панкреатита. В 2017 г. увидели свет Российский и Панъевропейский (HaPanEU) консенсусы, в 2018 г. — международный консенсус по панкреатиту минимальных изменений, в 2020 г. — клинические рекомендации Американского колледжа гастроэнтерологов, в 2021 г. — Британские клинические рекомендации. Многие их положения перекликаются. В настоящей обзорной статье были проанализированы основные положения последних рекомендаций с учетом возможности их адаптации к российской клинической практике.

In recent years, several consensus and guidelines for the diagnosis and treatment of chronic pancreatitis have been published. In 2017, the Russian and Pan-European (HaPanEU) consensus was published, in 2018 — the international consensus on minimal change pancreatitis, in 2020 — the clinical guidelines of the American College of Gastroenterology, in 2021 — the British clinical guidelines. Many of their provisions overlap. This review article analyzed the main provisions of the latest recommendations, taking into account the possibility of their adaptation to Russian clinical practice.

рекомендации по диагностике и лечениюхронический панкреатитэкзокринная панкреатическая недостаточность

recommendations for diagnosis and treatmentchronic pancreatitisexocrine pancreatic insufficiency

References1

Бордин Д. С., Кучерявый Ю. А. Ключевые позиции панъевропейских клинических рекомендаций по диагностике и лечению хронического панкреатита в фокусе гастроэнтеролога РМЖ. 2017. Т. 25. № 10. С. 730–737.

Bordin D.S., Kucheryavy Yu. A. The key points of the pan-European clinical guidelines for the diagnosis and treatment of chronic pancreatitis in the focus of gastroenterologist. RMJ. 2017, No 10, pp. 730–737. (in Russ.)

Кучерявый Ю. А., Кирюкова М. А., Дубцова Е. А., Бордин Д. С. Клинические рекомендации ACG-2020 по диагностике и лечению хронического панкреатита: обзор ключевых положений в практическом преломлении. Эффективная фармакотерапия. 2020. Т. 16. № 15. С. 60–73. DOI 10.33978/2307–3586–2020-16–15–60–72.

Kucheryavyy Yu.A., Kiryukova M. A., Dubtsova E. A., Bordin D. S. ACG-2020 Clinical Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis: Overview of Key Provisions in Practice. Effective pharmacotherapy. 2020, Vol. 16, No. 15, pp. 60–73. (in Russ.) DOI: 10.33978/2307–3586–2020–16–15–60–72.

Ивашкин В. Т., Маев И. В., Охлобыстин А. В. и соавт. Клинические рекомендации российской гастроэнтерологической ассоциации по диагностике и лечению экзокринной недостаточности поджелудочной железы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017. Т. 27. № 2. С. 54–80. doi: 10.22416/1382–4376–2017–27–2–54–80

Ivashkin V. T., Mayev I. V., Okhlobystin A. V., et al.. Diagnostics and treatment of exocrine pancreatic insufficiency: clinical guidelines of the Russian gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(2):54–80. (In Russ.) doi: 10.22416/1382–4376–2017–27–2–54–80.

Khatkov I.E., Maev I. V., Abdulkhakov S. R., Alekseenko S. A., et al. Russian consensus on exo- and endocrine pancreatic insufficiency after surgical treatment. Turk J Gastroenterol. 2021 Mar;32(3):225–239. doi: 10.5152/tjg.2021.20445.

Clinical guidelines [Chronic pancreatitis. Clinical guidelines of the Ministry of Health of the Russian Federation, 2020]. (in Russ.)

Löhr J.M., Dominguez-Munoz E., Rosendahl J., et al.; HaPanEU/UEG Working Group. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017 Mar;5(2):153–199. doi: 10.1177/2050640616684695.

Whitcomb D.C., Shimosegawa T., Chari S. T., et al.; Working Group for the International (IAP – APA – JPS – EPC) Consensus Guidelines for Chronic Pancreatitis. International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club. Pancreatology. 2018 Jul;18(5):516–527. doi: 10.1016/j.pan.2018.05.008.

Gardner T.B., Adler D. G., Forsmark C. E., Sauer B. G., Taylor J. R., Whitcomb D. C. ACG Clinical Guide line: Chronic Pancreatitis. Am J Gastroenterol. 2020 Mar;115(3):322–339. doi: 10.14309/ajg.0000000000000535.

Хатьков И. Е., Маев И. В., Абдулхаков С. Р., и др. Российский консенсус по диагностике и лечению хронического панкреатита. Терапевтический архив. 2017. Т. 89. № 2. C. 105–113. doi: 10.17116/terarkh2017892105–113.

Khatkov I. E., Maev I. V., Abdulkhakov S. R., et al. The Russian consensus on the diagnosis and treatment of chronic pancreatitis. Terapevticheskii arkhiv. 2017, Vol. 89, No. 2, pp. 105–113. (inn Russ.) doi: 10.17116/terarkh2017892105–113.

Phillips M.E., Hopper A. D., Leeds J. S., Roberts K. J., McGeeney L., Duggan S. N., Kumar R. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterol. 2021 Jun;8(1): e000643. doi: 10.1136/bmjgast-2021–000643.

Маев И. В., Кучерявый Ю. А., Андреев Д. Н. Экзокринная недостаточность поджелудочной железы: клиническое значение и подходы к коррекции с позиций доказательной медицины. Терапевтический архив. 2021. Т. 93. № 4. С. 509–515. doi: 10.26442/00403660.2021.04.200800.

Maev I.V., Kucheryavyy Yu.A., Andreev D. N. Exocrine pancreas insufficiency: clinical significance and approaches to correction from evidence medicine. Terapevticheskii Arkhiv = Ter. Arkh. 2021; 93 (4): 509–515. (in Russ.) doi: 10.26442/00403660.2021.04.200800.

Domínguez-Muñoz J.E., Iglesias- García J., Vilariño-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007 Apr;5(4):484–8. doi: 10.1016/j.cgh.2007.01.004. Erratum in: Clin Gastroenterol Hepatol. 2011 Dec;9(12):1108. PMID: 17445754.

Stevens T., Parsi M. A. Update on endoscopic pancreatic function testing. World J Gastroenterol. 2011 Sep 21;17(35):3957–61. doi: 10.3748/wjg.v17.i35.3957.

Vanga R.R., Tansel A., Sidiq S., El- Serag H.B., Othman M. O. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Aug;16(8):1220–1228.e4. doi: 10.1016/j.cgh.2018.01.027.

Маев И. В., Кучерявый Ю. А., Москалева А. Б. Хронический панкреатит: мифы и реалии. Фарматека. 2010. № 12. С. 24–31.

Maev I.V., Kucheryavyy Yu.A., Moskaleva A. B. Chronic pancreatitis: myths and realities. Pharmateca. 2010. No. 12, pp. 24–31. (In Russ.)

Muniz C.K., dos Santos J. S., Pfrimer K., Ferrioli E., Kemp R., Marchini J. S., Cunha S. F. Nutritional status, fecal elastase-1, and 13C-labeled mixed triglyceride breath test in the long-term after pancreaticoduodenectomy. Pancreas. 2014 Apr;43(3):445–50. doi: 10.1097/MPA.0000000000000048.

Dumasy V., Delhaye M., Cotton F., Deviere J. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol. 2004 Jul;99(7):1350–4. doi: 10.1111/j.1572-0241.2004.30661.x.

de la Iglesia- Garcia D., Vallejo- Senra N., IglesiasGarcia J., López-López A., Nieto L., Domínguez-Muñoz J. E. Increased Risk of Mortality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. J Clin Gastroenterol. 2018 Sep;52(8): e63-e72. doi: 10.1097/MCG.0000000000000917.

Frulloni L., Falconi M., Gabbrielli A., Gaia E., et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 2010 Nov; 42 Suppl 6: S381–406. doi: 10.1016/S1590–8658(10)60682–2.

Haas S., Krins S., Knauerhase A., Löhr M. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP. 2015 Jan 31;16(1):58–62. doi: 10.6092/1590–8577/2898.

Duggan S.N., Smyth N. D., O’Sullivan M., Feehan S., Ridgway P. F., Conlon K. C. The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract. 2014 Jun;29(3):348–54. doi: 10.1177/0884533614528361.

Girish B.N., Rajesh G., Vaidyanathan K., Balakrishnan V. Zinc status in chronic pancreatitis and its relationship with exocrine and endocrine insufficiency. JOP. 2009 Nov 5;10(6):651–6. PMID: 19890187.

Bachmann J., Ketterer K., Marsch C., et al. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer. 2009 Jul 28;9:255. doi: 10.1186/1471–2407–9–255.

Kondrup J., Rasmussen H. H., Hamberg O., Stanga Z.; Ad Hoc ESPEN Working Group. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003 Jun;22(3):321–36. doi: 10.1016/s0261–5614(02)00214–5.

Kucheryavyy Yu.A., Andreev D. N. Nutritional status in patients with chronic pancreatitis. J. Nutritional Therapeutics. 2014. 3 (3). 122–132.

Tignor A.S., Wu B. U., Whitlock T. L., Lopez R., Repas K., Banks P. A., Conwell D. High prevalence of low-trauma fracture in chronic pancreatitis. Am J Gastroenterol. 2010 Dec;105(12):2680–6. doi: 10.1038/ajg.2010.325.

Duggan S.N., Purcell C., Kilbane M., et al. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study. Am J Gastroenterol. 2015 Feb;110(2):336–45. doi: 10.1038/ajg.2014.430.

Sikkens E.C., Cahen D. L., Koch A. D., Braat H., Poley J. W., Kuipers E. J., Bruno M. J. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013 May-Jun;13(3):238–42. doi: 10.1016/j.pan.2013.02.008.

Reddy S.V., Ramesh V., Bhatia E. Double blind randomized control study of intramuscular vitamin D3 supplementation in tropical calcific pancreatitis. Calcif Tissue Int. 2013 Jul;93(1):48–54. doi: 10.1007/s00223-013–9726–6.

Nakamura T., Takebe K., Imamura K., et al. Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). Acta Gastroenterol Belg. 1996 JanMar;59(1):10–14. PMID: 8686411.

Livingstone C., Davis J., Marvin V., Morton K. Vitamin A deficiency presenting as night blindness during pregnancy. Ann Clin Biochem. 2003 May;40(Pt 3):292–4. doi: 10.1258/000456303321610655.

Martínez-Moneo E., Stigliano S., Hedström A., et al. Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis. Pancreatology. 2016 Nov- Dec;16(6):988–994. doi: 10.1016/j.pan.2016.09.008.

Кучерявый Ю. А., Бидеева Т. В., Самойлова А. Б., Маев И. В. Диагностика панкреатической недостаточности: современные представления. Фокус на нутритивный статус. Фарматека. 2017. № 13 (346). С. 64–70.

Kucheryavy Yu.A., Bideeva T. V., Samoilova A. B., Maev I. V. Diagnostics of pancreatic insufficiency: modern views. Focus on nutritional status. Pharmateca. 2017;13 (346): 64–70. (In Russ.)

Хатьков И. Е., Маев И. В., Бордин Д. С. и соавт. Российский консенсус по диагностике и лечению хронического панкреатита: акцент на нутритивный статус и вопросы питания. Фарматека. 2016. № S5. С. 27–32.

Khatkov I.E., Mayev I. V., Bordin D. S. et al. Russian consensus on the diagnosis and treatment of chronic pancreatitis: emphasis on nutritional status and nutritional issues. Pharmateca. 2016;(S5):27–32. (In Russ.)

Lindkvist B, Domínguez-Muñoz JE, Luaces-Regueira M, Castiñeiras-Alvariño M, Nieto-Garcia L, Iglesias-Garcia J. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012 Jul-Aug;12(4):305–10. doi: 10.1016/j.pan.2012.04.006. Epub 2012 May 4. PMID: 22898630.

Кузьмина Т. Н., Никольская К. А., Кирюкова М. А., Малых М. В., Чеботарева М. В., Кучерявый Ю. А., Бордин Д. С. Единство и различие стратегии клинического питания и нутритивной поддержки больных хроническим панкреатитом: национальные рекомендации и рекомендации ESPEN. Эффективная фармакотерапия. 2021. Т. 17. № 16. С. 76–91. DOI 10.33978/2307–3586–2021–17–16–76–90

Kuzmina T.N., Nikolskaya K. A., Kiryukova M. A., Malykh M. V., Chebotareva M. V., Kucheravyy Yu.A., Bordin D. S. Unity and Difference of Clinical Nutrition and Nutritional Support Strategy for Patients with Chronic Pancreatitis: National Recommendations and Recommendations of ESPEN. Effective pharmacotherapy. 2021;17(16):76–91. (In Russ.) DOI 10.33978/2307–3586-2021–17–16–76–90

Graham D. Y. An enteric- coated pancreatic enzyme preparation that works. Dig Dis Sci. 1979 Dec;24(12):906–9. doi: 10.1007/BF01311943. PMID: 510089.

Graham D. Y. An enteric-coated pancreatic enzyme preparation that works. Dig Dis Sci. 1979 Dec;24(12):906–9. doi: 10.1007/BF01311943. PMID: 510089.

Dutta S.K., Rubin J., Harvey J.. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology. 1983 Mar;84(3):476–82. PMID: 6549746.

Lankisch P.G., Lembcke B., Göke B., Creutzfeldt W. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol. 1986 Dec;24(12):753–7. PMID: 3548109.

Halgreen H., Pedersen N. T., Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol. 1986 Jan;21(1):104–8. doi: 10.3109/00365528609034631. PMID: 3633631.

Gouerou H., Dain M. P., Parrondo I., Poisson D., Bernades P. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study. Int J Pancreatol. 1989;5 Suppl:45–50. PMID: 2702250.

Jørgensen B.B., Pedersen N. T., Worning H. Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency. Scand J Gastroenterol. 1991 Mar;26(3):321–6. doi: 10.3109/00365529109025049.

Paris J.C. A multicentre double-blind placebo-controlled study of the effect of a pancreatic enzyme formulation (Panzytrat 25000) on impaired lipid digestion in adults with chronic pancreatitis. Drug Invest. 1993; 5: 229–237.

Delhaye M., Meuris S., Gohimont A. C., Buedts K., Cremer M. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Eur J Gastroenterol Hepatol. 1996 Jul;8(7):699–703. PMID: 8853261.

Opekun A. R. Jr, Sutton F. M. Jr, Graham D. Y..Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults. Aliment Pharmacol Ther. 1997 Oct;11(5):981–6. doi: 10.1046/j.1365–2036.1997.00245.x.

Halm U., Löser C., Löhr M., Katschinski M., Mössner J. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther. 1999 Jul;13(7):951–7. doi: 10.1046/j.1365–2036.1999.00566.x.

O’Keefe S.J., Cariem A. K., Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol. 2001 Apr;32(4):319–23. doi: 10.1097/00004836–200104000–00008.

Domínguez-Muñoz J.E., Iglesias- García J., IglesiasRey M., Figueiras A., Vilariño-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2005 Apr 15;21(8):993–1000. doi: 10.1111/j.1365-2036.2005.02390.x.

Vecht J., Symersky T., Lamers C. B., Masclee A. A. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. J Clin Gastroenterol. 2006 Sep;40(8):721–5. doi: 10.1097/00004836–200609000–00012.

Safdi M., Bekal P. K., Martin S., Saeed Z. A., Burton F., Toskes P. P. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebocontrolled, parallel group trial in subjects with chronic pancreatitis. Pancreas. 2006 Aug;33(2):156–62. doi: 10.1097/01.mpa.0000226884.32957.5e.

Whitcomb D.C., Lehman G. A., Vasileva G., MaleckaPanas E., Gubergrits N., Shen Y., Sander-Struckmeier S., Caras S. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol. 2010 Oct;105(10):2276–86. doi: 10.1038/ajg.2010.201.

Toskes P.P., Secci A., Th ieroff-Ekerdt R.; ZENPEP Study Group. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas. 2011 Apr;40(3):376–82. doi: 10.1097/MPA.0b013e31820b971c.

Thorat V., Reddy N., Bhatia S., Bapaye A., Rajkumar J. S., Kini D. D., Kalla M. M., Ramesh H. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis – a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2012 Sep;36(5):426–36. doi: 10.1111/j.1365–2036.2012.05202.x.

Shafiq N., Rana S., Bhasin D., Pandhi P., Srivastava P., Sehmby S. S., Kumar R., Malhotra S. Pancreatic enzymes for chronic pancreatitis. Cochrane Database Syst Rev. 2009 Oct 7;(4): CD006302. doi: 10.1002/14651858.CD006302.pub2.

de la Iglesia- García D., Huang W., Szatmary P., Baston-Rey I., Gonzalez-Lopez J., Prada-Ramallal G., Mukherjee R., Nunes Q. M., Domínguez-Muñoz J.E., Sutton R.; NIHR Pancreas Biomedical Research Unit Patient Advisory Group. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2017 Aug;66(8):1354-1355. doi: 10.1136/gutjnl-2016–312529.

Бидеева Т. В., Маев И. В., Кучерявый Ю. А., и др. Эффективность заместительной ферментной терапии с использованием микрокапсулированных препаратов панкреатина при коррекции нутритивного статуса у пациентов с хроническим панкреатитом: проспективное наблюдательное исследование. Терапевтический архив. 2020. Т. 92. № 1. C. 30–35. doi: 10.26442/00403660.2020.01.000488

Bideeva T.V., Maev I. V., Kucheryavy y Y. A., Andreev D. N., Shah Y. S., Lobanova E. G., Zaborovskiy A. V., Levchenko A. I. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study]. Ter Arkh. 2020 Jan 15;92(1):30–35. Russian. doi: 10.26442/00403660.2020.01.000488.

Gubergrits N., Malecka- Panas E., Lehman G. A., Vasileva G., Shen Y., Sander-Struckmeier S., Caras S., Whitcomb D. C. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther. 2011 May;33(10):1152–61. doi: 10.1111/j.1365-2036.2011.04631.x.

Ramesh H., Reddy N., Bhatia S., Rajkumar J. S., Bapaye A., Kini D., Kalla M., Thorat V. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013 Mar-Apr;13(2):133–9. doi: 10.1016/j.pan.2013.01.009.

D’Haese J.G., Ceyhan G. O., Demir I. E., Layer P., Uhl W., Löhr M., Rychlik R., Pirilis K., Zöllner Y., Gradl B., Foerster D., Möbius J., Henniges F., Friess H. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life. Pancreas. 2014 Aug;43(6):834–41. doi: 10.1097/MPA.0000000000000131.

Бидеева Т. В., Андреев Д. Н., Кучерявый Ю. А., Маев И. В. Динамика уровня витамина D у больных хроническим панкреатитом на фоне заместительной ферментной терапии. Медицинский Совет. 2019;(3):156–160. DOI: 10.21518/2079–701X-2019–3-156–160.

Bideyeva T. V., Andreyev D. N., Kucheryavy Yu.A., Maev I. V. Dynamics of vitamin D level in patients with chronic pancreatitis on the background of enzyme replacement therapy. Meditsinskiy sovet = Medical Council. 2019;(3):156–160. (In Russ.) DOI: 10.21518/2079-701X-2019–3–156–160.

Iglesia D., Avci B., Kiriukova M., et al. Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis. United European Gastroenterol J. 2020 Nov;8(9):1115–1125. doi: 10.1177/2050640620938987.

Lindkvist B., Phillips M. E., Domínguez- Muñoz J. E. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Pancreatology. 2015 Nov-Dec;15(6):589–97. doi: 10.1016/j.pan.2015.07.001.

Маев И. В., Кучерявый Ю. А. Заместительная ферментная терапия при панкреатической недостаточности. Клинические перспективы гастроэнтерологии, гепатологии. 2005. № 5. С. 19–28.

Maev I.V., Kucheryavyy Yu. A. Enzyme replacement therapy for pancreatic insufficiency. Clinical perspectives of gastroenterology, hepatology. 2005;(5):19–28. (in Russ.)

Кучерявый Ю. А., Оганесян Т. С. Синдром избыточного бактериального роста // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2010. Т. 20. № 5. С. 63–68.

Kucheryavyy Yu.A., Oganesyan T. S. Syndrome of bacterial overgrowth. Russian journal of gastroenterology, hepatology, coloproctology. 2010;20(5):63–68. (In Russ.)

Бордин Д. С., Осипенко Ю. В., Винокурова Л. В., Дубцова Е. А. Влияние избыточного бактериального роста в тонкой кишке на течение хронического панкреатита // Экспериментальная и клиническая гастроэнтерология. 2012. № 7. С. 43–47.

Bordin D.S., Osipenko Yu.V., Vinokurova L. V., Dubtsova E. A. Influence of bacterial overgrowth in the small intestine on the course of chronic pancreatitis. Experimental and clinical gastroenterology. 2012;(7):43–47. (in Russ.)

Маев И. В., Бидеева Т. В., Кучерявый Ю. А., Андреев Д. Н., Буеверов А. О. Фармакотерапия хронического панкреатита с позиций современных клинических рекомендаций. Терапевтический архив 2018;90(8):81–85. doi: 10.26442/terarkh201890881–85

Maev I.V., Bideeva Т. В., Kucheryavyy Y. A., Andreev D. N., Bueverov A. O. Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations. Ter Arkh. 2018 Aug 27;90(8):81–85. (in Russ.) doi: 10.26442/terarkh201890881–85.

Arvanitakis M., Ockenga J., Bezmarevic M., et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020 Mar;39(3):612–631. doi: 10.1016/j.clnu.2020.01.004.

Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD008227. doi: 10.1002/14651858.CD008227.pub3. Update in: Cochrane Database Syst Rev. 2020 Aug 5;8:CD008227. PMID: 27878805; PMCID: PMC6734127

The authors declare that there are no conflicts of interest present.